Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value
$122.94+0.23 (+0.19%)
Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –
Haemonetics cash
Cash and short-term investments held at the end of each period.
Haemonetics's cash was $260.71M at Sep 26, 2026. For fiscal 2026 it was $245.44M, down 20.0% from the year before. Over ten years it grew 7.9% a year on average. The highest annual figure on record is $306.76M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $245.44M | -20.0% |
| FY2025 | Mar 29, 2025 | $306.76M | +71.6% |
| FY2024 | Mar 30, 2024 | $178.80M | -37.1% |
| FY2023 | Apr 1, 2023 | $284.47M | +9.6% |
| FY2022 | Apr 2, 2022 | $259.50M | +34.9% |
| FY2021 | Apr 3, 2021 | $192.31M | +40.1% |
| FY2020 | Mar 28, 2020 | $137.31M | -18.9% |
| FY2019 | Mar 30, 2019 | $169.35M | -6.0% |
| FY2018 | Mar 31, 2018 | $180.17M | +29.1% |
| FY2017 | Apr 1, 2017 | $139.56M | +21.2% |
| FY2016 | Apr 2, 2016 | $115.12M | -28.3% |
| FY2015 | Mar 28, 2015 | $160.66M | -16.5% |
| FY2014 | Mar 29, 2014 | $192.47M | +7.5% |
| FY2013 | Mar 30, 2013 | $179.12M | -21.7% |
| FY2012 | Mar 31, 2012 | $228.86M | +16.3% |
| FY2011 | Apr 2, 2011 | $196.71M | +39.0% |
| FY2010 | Apr 3, 2010 | $141.56M | -9.7% |
| FY2009 | Mar 28, 2009 | $156.72M | +17.3% |
| FY2008 | Mar 29, 2008 | $133.55M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 26, 2026 | $260.71M | -12.0% |
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $223.38M | -23.7% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | $245.44M | -20.0% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $363.37M | +13.3% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $296.43M | -1.0% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $292.90M | -15.0% |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $306.76M | +71.6% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $320.85M | +65.4% |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $299.28M | -14.7% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | $344.43M | +20.5% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $178.80M | -37.1% |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | $193.98M | -13.4% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $351.01M | +45.5% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $285.72M | +32.9% |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | $284.47M | +9.6% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $224.00M | -5.4% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $241.20M | +25.4% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | $214.95M | +23.9% |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $259.50M | +34.9% |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $236.88M | +25.3% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $192.42M | -31.1% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | $173.46M | -37.1% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | $192.31M | +40.1% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $189.00M | +49.5% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $279.17M | +149.2% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $275.73M | +44.9% |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $137.31M | -18.9% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $126.42M | -18.4% |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $112.03M | -43.9% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | $190.23M | -1.0% |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $169.35M | -6.0% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | $154.87M | -38.4% |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $199.76M | -1.9% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $192.11M | +11.9% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $180.17M | +29.1% |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | $251.59M | +94.1% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $203.62M | – |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $171.74M | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | $139.56M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $129.64M | – |
See a number that looks wrong?